Taysha Gene Therapies grants new hires 384,000 RSUs, options for 92,400 shares under inducement plan

• Taysha Gene Therapies granted four new employees 384,000 restricted stock units under its 2023 Inducement Plan.
• Each RSU award vests in four equal annual installments starting on the first anniversary of the vesting commencement date.
• The company also issued options covering 92,400 shares with an exercise price of $4.74.
• Options run for 10 years. Vesting spans four years, with 25% after one year, then monthly over 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Taysha Gene Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020800PRIMZONEFULLFEED9838327) on October 02, 2026, and is solely responsible for the information contained therein.